Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs - Real World Outcomes
Published in: Drugs - Real World Outcomes 2/2017

Open Access 01-06-2017 | Original Research Article

Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden

Authors: Cecilia Peterson, Maria Gustafsson

Published in: Drugs - Real World Outcomes | Issue 2/2017

Login to get access

Abstract

Background

Polypharmacy and increased sensitivity to side effects cause adverse drug events, drug–drug interactions and medication errors in the elderly.

Objective

The objective of this study was to investigate the prevalence and type of drug-related problems and associated factors among patients admitted to a clinical pharmacist service-naïve medical ward in an inland hospital in northern Sweden.

Methods

During September–November 2015 and February–April 2016, clinical pharmacists working as part of a ward team on the medical ward conducted 103 medication reviews. Drug-related problems were identified and classified. Associated factors, drug classes and specific drugs involved were also investigated.

Results

The clinical pharmacists identified 133 drug-related problems in 66% [68/103] of the study population. The most common drug-related problems in this study were inappropriate drug use and interactions. Cardiovascular drugs and psychotropic drugs were most commonly involved. Drug-related problems were more frequently observed at higher age, increasing number of drugs prescribed and in patients with reduced renal function. In the multivariate analysis, only the number of prescribed drugs was still significant.

Conclusion

Drug-related problems were commonly observed among patients admitted to the medical ward. Medication reviews conducted by clinical pharmacists as part of a ward team resulted in several interventions to improve the patients’ drug treatment.
Literature
1.
2.
Walker R, Whittlesea C. Clinical pharmacy and therapeutics, 5th ed. Vol. Edinburgh: Elsevier Ltd; 2012. p. 2–7, 149–151.
3.
Caratozzolo S, Gipponi S, Marengoni A, et al. Potentially serious drug–drug interactions in older patients hospitalized for acute ischemic and hemorrhagic stroke. Eur Neurol. 2016;76:161–6.CrossRefPubMed
4.
5.
Blix HS, Viktil KK, Reikvam Å, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60:651–8.CrossRefPubMed
6.
Salvi F, Marchetti A, D’Angelo F, et al. Adverse drug events as a cause of hospitalization in older adults. Drug Saf. 2012;35:29–45.CrossRefPubMed
7.
8.
Gustafsson M, Sjölander M, Pfister B et al. Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial. Eur J Clin Pharmacol. 2017. doi:10.​1007/​s00228-017-2249-8.
9.
Graabæk T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112:359–73.CrossRefPubMed
10.
Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev. 2010;7:CD000336.
11.
Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns M, et al. Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses. J Am Geriatr Soc. 2013;61:1119–27.CrossRefPubMed
12.
Jiang S-P, Zhu Z-Y, Ma K-F, et al. Impact of pharmacist antimicrobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit. Scand J Infect Dis. 2013;45:891–9.CrossRefPubMed
13.
Salgado TM, Moles R, Benrimoj SI, et al. Pharmacists’ interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2012;27:276–92.CrossRefPubMed
14.
15.
16.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.CrossRefPubMed
17.
18.
Cipolle R, Strand L, Morely P. Pharmaceutical Care Practice. 2nd ed. New York: The McGraw-Hill Companies inc; 2004. p. 13.
19.
20.
Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33:549–57.CrossRefPubMed
21.
Kaufmann CP, Stämpfli D, Hersberger KE, et al. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5:e006376.CrossRefPubMedPubMedCentral
22.
Gustafsson M, Sjölander M, Pfister B, et al. Drug- related hospital admissions among old people with dementia. Eur J Clin Pharmacol. 2016;72:1143–53.CrossRefPubMed
23.
Khanal A, Peterson G, Castelino R, et al. Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings. Drugs Aging. 2015;32:391–400.CrossRefPubMed
24.
Sönnerstam E, Sjölander M, Gustafsson M. Inappropriate prescription and renal function among older patients with cognitive impairment. Drugs Aging. 2016;12:1–11.
25.
Walter H. Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals. 2010;3:2291–321.CrossRef
26.
Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6–14.CrossRefPubMedPubMedCentral
27.
Juurlink DN, Mamdani M, Kopp A, et al. Drug–drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652–8.CrossRefPubMed
28.
Milos V, Rekman E, Bondesson Å, et al. Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging. 2013;30:235–46.CrossRefPubMed
29.
Chau SH, Jansen APD, Ven PM, et al. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands. Int J Clin Pharm. 2016;38:46–53.CrossRefPubMed
30.
Kjeldsen LJ, Birkholm T, Fischer H, et al. Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals. Int J Clin Pharm. 2014;36:734–41.CrossRefPubMed
31.
Ungprasert P, Srivali N, Thongprayoon C. Nonsteroidal anti-inflammatory drugs and risk of incident heart failure: a systematic review and meta-analysis of observational studies. Clin Cardiol. 2016;39:111–8.CrossRefPubMed
32.
Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. The Lancet. 1994;343:1075–8.CrossRef
33.
Al Hamid A, Ghaleb M, Aljadhey H, et al. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78:202–17.CrossRefPubMed
34.
Urbina O, Ferrández O, Grau S, et al. Design of a score to identify hospitalized patients at risk of drug-related problems. Pharmacoepidemiol Drug Saf. 2014;23:923–32.CrossRefPubMed
35.
Belaiche S, Romanet T, Allenet B, et al. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study. J Nephrol. 2012;25:782–8.CrossRefPubMed
36.
Blix HS, Viktil KK, Moger TA, et al. Use of renal risk drugs in hospitalized patients with impaired renal function—an underestimated problem? Nephrol Dial Transpl. 2006;21:3164–71.CrossRef
37.
Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly. Drug Saf. 2007;30:911–8.CrossRefPubMed
38.
Boeker EB, Ram K, Klopotowska JE, et al. An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients. Br J Clin Pharmacol. 2015;79:548–57.CrossRefPubMed
39.
Alassaad A, Bertilsson M, Gillespie U, et al. The effects of pharmacist intervention on emergency department visits in patients 80 years and older: subgroup analyses by number of prescribed drugs and appropriate prescribing. PLoS One. 2014;9:e111797.CrossRefPubMedPubMedCentral
Metadata
Title
Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden
Authors
Cecilia Peterson
Maria Gustafsson
Publication date
01-06-2017
Publisher
Springer International Publishing
Published in
Drugs - Real World Outcomes / Issue 2/2017
Print ISSN: 2199-1154
Electronic ISSN: 2198-9788
DOI
https://doi.org/10.1007/s40801-017-0108-7

Other articles of this Issue 2/2017

Drugs - Real World Outcomes 2/2017 Go to the issue

Original Research Article

Characterization of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to Kenyatta National Hospital: A Retrospective Cross-Sectional Study

Commentary

In the Real-World, Kids Use Medications and Devices

Original Research Article

Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case–Control Study in Australia

Original Research Article

Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study

Short Communication

Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007–15: Report from the Medical Products Agency